Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Jan 2007 04:48 PM
RNS
Total Voting Rights-Amendment
02 Jan 2007 03:47 PM
RNS
Total Voting Rights-Amendment
22 Dec 2006 11:55 AM
RNS
Total Voting Rights
21 Dec 2006 07:00 AM
RNS
GSK Lentivector Licence
19 Dec 2006 05:51 PM
RNS
Holding(s) in Company
19 Dec 2006 07:00 AM
RNS
Licensing Agreement
08 Dec 2006 04:55 PM
RNS
Holding(s) in Company
08 Dec 2006 07:00 AM
RNS
Positive Opinion on Trovax
05 Dec 2006 07:00 AM
RNS
Holding(s) in Company
21 Nov 2006 09:31 AM
RNS
Blocklisting Interim Review
13 Nov 2006 07:00 AM
RNS
Prosavin preclinical data
09 Nov 2006 07:00 AM
RNS
Phase II Results - Trovax
07 Nov 2006 07:00 AM
RNS
Phase III Trial in Trovax
06 Oct 2006 07:00 AM
RNS
Presentation at Conference
02 Oct 2006 07:00 AM
RNS
Gene Therapy for Blindness
25 Sep 2006 02:32 PM
RNS
Holding(s) in Company
20 Sep 2006 10:08 AM
RNS
Holding(s) in Company
07 Sep 2006 10:54 AM
RNS
Interest in Share Options
05 Sep 2006 07:01 AM
RNS
SWOG in phase 2 Trovax trial
05 Sep 2006 07:00 AM
RNS
Interim Results
21 Aug 2006 07:00 AM
RNS
Trovax at Cancer Conference
03 Aug 2006 04:00 PM
RNS
Holding(s) in Company
02 Aug 2006 07:00 AM
RNS
Notice of Interim Results
31 Jul 2006 07:00 AM
RNS
Trovax Update & Clarification
18 Jul 2006 04:09 PM
RNS
Holding(s) in Company
06 Jul 2006 04:31 PM
RNS
Holding(s) in Company
05 Jul 2006 04:54 PM
RNS
Director/PDMR Shareholding
26 Jun 2006 11:43 AM
RNS
Holding(s) in Company
26 Jun 2006 07:00 AM
RNS
Prosavin Patent
21 Jun 2006 07:00 AM
RNS
Piper Jaffray Health Care
14 Jun 2006 07:00 AM
RNS
SUIT AGAINST OPEN BIOSYSTEMS
12 Jun 2006 04:00 PM
RNS
Holding(s) in Company
07 Jun 2006 07:00 AM
RNS
Phase II results - TROVAX
23 May 2006 07:00 AM
RNS
Phase II Trial Trovax
22 May 2006 04:30 PM
RNS
Holding(s) in Company
18 May 2006 07:00 AM
RNS
Blocklisting Interim Review
16 May 2006 08:51 AM
RNS
Director/PDMR Shareholding
12 May 2006 07:00 AM
RNS
Agreement with FDA
04 May 2006 11:53 AM
RNS
Annual General Meeting 06
02 May 2006 07:01 AM
RNS
RETINOSTAT
20 Apr 2006 05:38 PM
RNS
Holding(s) in Company
11 Apr 2006 04:26 PM
RNS
Annual Report and Accounts
11 Apr 2006 08:21 AM
RNS
Annual Information Update
06 Apr 2006 01:23 PM
RNS
Holding(s) in Company
30 Mar 2006 07:01 AM
RNS
Clinical Trial Results
24 Mar 2006 12:40 PM
RNS
Holding(s) in Company
23 Mar 2006 11:03 AM
RNS
Director/PDMR Shareholding
16 Mar 2006 04:04 PM
RNS
Director/PDMR Shareholding
14 Mar 2006 07:00 AM
RNS
Preliminary Results
10 Mar 2006 07:00 AM
RNS
VIRxSYS Corporation Licence

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings